Perry A. Lange
Partner at wilmerhale.com
Perry Lange represents clients in diverse antitrust matters before US courts, the US Department of Justice and Federal Trade Commission, state attorneys general and Congress. He has extensive experience litigating antitrust cases, including trials and appeals, securing merger clearance, and defending state and federal investigations. He has also represented a diverse set of clients in antitrust policy matters such as congressional investigations and hearings in both the House and Senate. Source
Articles
-
Mar 25, 2024 |
wilmerhale.com | Leon Greenfield |Nana Wilberforce |Perry A. Lange |Hartmut Schneider |Dominic Vote |Jonathan R. Wright | +2 more
The healthcare industry remains a focal point of President Biden’s antitrust agenda. The President’s July 2021 Executive Order on Promoting Competition in the American Economy called on federal agencies to focus antitrust enforcement efforts on health care, among other industries, and to coordinate on oversight, investigations, and remedies where agency jurisdiction overlaps. The Federal Trade Commission (FTC), the Department of Justice Antitrust Division (DOJ), and the Department of Health and Human Services (HHS) later announced plans to address antitrust concerns in the healthcare industry. FTC Chair Lina M. Khan highlighted ongoing healthcare-related enforcement initiatives in a February 2024 speech before the American Medical Association. The FTC, DOJ, and HHS launched an interagency inquiry into private equity and corporate ownership in health care shortly thereafter. In this client alert, we summarize the latest federal antitrust activities in the healthcare industry.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →